Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events: A randomized controlled trial
Articolo
Data di Pubblicazione:
2012
Tipologia CRIS:
14.a.1 Articolo su rivista
Keywords:
Cardiovascular events; Pioglitazone; Randomized Controlled Trial; Sulfonylureas; Type 2 diabetes; Aged; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Endpoint Determination; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Quality of Life; Risk Factors; Sulfonylurea Compounds; Surveys and Questionnaires; Thiazolidinediones; Treatment Outcome; Medicine (miscellaneous); Nutrition and Dietetics; Endocrinology, Diabetes and Metabolism; Cardiology and Cardiovascular Medicine
Elenco autori:
Vaccaro, O.; Masulli, M.; Bonora, E.; Del Prato, S.; Giorda, C. B.; Maggioni, A. P.; Mocarelli, P.; Nicolucci, A.; Rivellese, A. A.; Squatrito, S.; Riccardi, G.
Link alla scheda completa:
Pubblicato in: